Composite CCHG Biomarker Associates with Elevated Stroke Risk in Cohort Study
A nine-year cohort study of 6,804 adults found that the novel CCHG index, combining cholesterol, glucose, and C-reactive protein, was ...
A nine-year cohort study of 6,804 adults found that the novel CCHG index, combining cholesterol, glucose, and C-reactive protein, was ...
A narrative review proposes a two-phase framework for third nerve palsy, sequencing acute neuroimaging triage in the first twelve weeks ...
A single-center cross-sectional study of 186 NSTEACS patients found that the extent of cervicocephalic atherosclerosis, rather than its severity, was ...
A Ga-FAPI-04 PET/CMR study found that 74% of post-ablation atrial fibrillation patients showed increased atrial fibroblast activation during a stable ...
A decade-spanning cross-sectional study of community-dwelling adults at high risk of stroke finds that higher homocysteine levels and waist-to-height ratio ...
A large retrospective cohort study found that adults aged 80 and older with atrial fibrillation who continued anticoagulation had lower ...
A nationwide cohort study found that high C-reactive protein–triglyceride-glucose index levels and frailty were independently and jointly associated with higher ...
A time-series study of 2,425 first-ever ischaemic stroke patients in Changchun, China, finds that lower temperatures raise stroke risk two ...
A new diffusion imaging study finds that people with vulnerable carotid plaques show widespread white matter damage linked to inflammatory ...
High-resolution vessel wall MRI reveals that ischemic stroke in moyamoya disease is driven by diffuse arterial narrowing and constrictive remodeling, ...
Restless legs syndrome (RLS) and periodic limb movements (PLMs) have emerged as significant areas of concern in the broader context ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.